创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: Introduction to the characteristics of humanized models of the immune system

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-12 14:04
  • Views:

(Summary description)In the continuous progress of biomedical research, humanized models of the immune system have become a key tool for researchers to explore disease mechanisms and develop new drugs and treatments. By virtue of its unique design and excellent features, InnoModels' humanized model of the immune system brings new perspectives and possibilities to biomedical research

InnoModels: Introduction to the characteristics of humanized models of the immune system

(Summary description)In the continuous progress of biomedical research, humanized models of the immune system have become a key tool for researchers to explore disease mechanisms and develop new drugs and treatments. By virtue of its unique design and excellent features, InnoModels' humanized model of the immune system brings new perspectives and possibilities to biomedical research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-12 14:04
  • Views:
Information

In the continuous progress of biomedical research, humanized models of the immune system have become a key tool for researchers to explore disease mechanisms and develop new drugs and treatments. By virtue of its unique design and excellent features, InnoModels' humanized model of the immune system brings new perspectives and possibilities to biomedical research.
Highly simulate the human immune environment
By introducing human immune cells into experimental animals through advanced gene editing and cell engineering technologies, the humanized model of the immune system of InnoModels Biotechnology has constructed an experimental system that highly simulates the human immune environment. This feature enables researchers to study the pathogenesis of diseases, immune responses and drug efficacy under conditions closer to the real human environment, thus improving the reliability and practicality of experimental results.
Customized to meet research needs
InnoModels' humanized models of the immune system provide personalized customization services, tailoring the models to the specific needs and research directions of the researchers. Whether it is a specific immune cell type, disease background or therapeutic strategy, InnoModels Biotechnology can provide researchers with precise experimental models and solutions to meet the specific needs of different research fields.
Stable and Reliable Experimental Conditions
InnoModels' humanized models of the immune system excel in terms of experimental conditions. They have advanced experimental facilities, strict experimental operation and quality control system to ensure the stability and reliability of the experimental process. In addition, InnoModels Biotechnology also focuses on the traceability of experimental data, keeping detailed experimental records and data, which is convenient for researchers to access and verify the experimental results at any time.

 


Wide range of applications
The humanized immune system model of InnoModels has a wide range of applications and is suitable for research on a variety of diseases. Whether in the field of autoimmune diseases, infectious diseases or tumor immunotherapy, InnoModels' models can provide researchers with powerful experimental tools. This feature makes InnoModels' humanized models of the immune system a powerful assistant in biomedical research.
Strong Technical Support and Collaboration Network
InnoModels Biotechnology not only provides high-quality humanized models of the immune system, but also offers comprehensive technical support and solutions for researchers. Their professional team has rich experimental experience and technical capabilities, and is able to provide researchers with one-stop services from model construction to data analysis. In addition, InnoModels Biotechnology has established an extensive cooperation network with domestic and international research institutes, universities and hospitals to promote the application and development of humanized models of the immune system through cooperation, exchange and resource sharing.
In conclusion, with its high degree of simulation of the human immune environment, personalized customization, stable and reliable experimental conditions, wide range of applications and strong technical support and cooperation network, InnoModels' humanized model of the immune system has become a treasure in the field of biomedical research. It provides researchers with powerful experimental tools and opens a new chapter in disease research. With the continuous progress and innovation of technology, the humanized model of the immune system of InnoModels will continue to play an important role in biomedical research and make greater contributions to the health of mankind.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司